Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain
Gespeichert in:
| Format: | Tagungsbericht Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Amsterdam [u.a.]
Elsevier
2008
|
| Ausgabe: | [Bindeeinheit] |
| Schriftenreihe: | EJC
Supplements ; 6,5 |
| Schlagworte: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV023275364 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t| | ||
| 008 | 080424s2008 xx ad|| |||| 10||| eng d | ||
| 035 | |a (OCoLC)635353516 | ||
| 035 | |a (DE-599)BVBBV023275364 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 | ||
| 245 | 1 | 0 | |a Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer |b based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| 250 | |a [Bindeeinheit] | ||
| 264 | 1 | |a Amsterdam [u.a.] |b Elsevier |c 2008 | |
| 300 | |a 31 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a EJC : Supplements |v 6,5 | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 0 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 711 | 2 | |a European Cancer Conference |n 14 |d 2007 |c Barcelona |j Sonstige |0 (DE-588)6517874-9 |4 oth | |
| 830 | 0 | |a EJC |v Supplements ; 6,5 |w (DE-604)BV017615175 |9 6,5 | |
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-016460272 | |
Datensatz im Suchindex
| _version_ | 1819266341577687041 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV023275364 |
| ctrlnum | (OCoLC)635353516 (DE-599)BVBBV023275364 |
| edition | [Bindeeinheit] |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01413nam a2200361 cb4500</leader><controlfield tag="001">BV023275364</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">080424s2008 xx ad|| |||| 10||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)635353516</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023275364</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer</subfield><subfield code="b">based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">[Bindeeinheit]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Amsterdam [u.a.]</subfield><subfield code="b">Elsevier</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">31 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">EJC : Supplements</subfield><subfield code="v">6,5</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">European Cancer Conference</subfield><subfield code="n">14</subfield><subfield code="d">2007</subfield><subfield code="c">Barcelona</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)6517874-9</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">EJC</subfield><subfield code="v">Supplements ; 6,5</subfield><subfield code="w">(DE-604)BV017615175</subfield><subfield code="9">6,5</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016460272</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV023275364 |
| illustrated | Illustrated |
| indexdate | 2024-12-23T20:59:40Z |
| institution | BVB |
| institution_GND | (DE-588)6517874-9 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016460272 |
| oclc_num | 635353516 |
| open_access_boolean | |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 31 S. Ill., graph. Darst. |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Elsevier |
| record_format | marc |
| series | EJC |
| series2 | EJC : Supplements |
| spelling | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain [Bindeeinheit] Amsterdam [u.a.] Elsevier 2008 31 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier EJC : Supplements 6,5 Therapie (DE-588)4059798-2 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Brustkrebs (DE-588)4008528-4 s Therapie (DE-588)4059798-2 s 1\p DE-604 European Cancer Conference 14 2007 Barcelona Sonstige (DE-588)6517874-9 oth EJC Supplements ; 6,5 (DE-604)BV017615175 6,5 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain EJC Therapie (DE-588)4059798-2 gnd Brustkrebs (DE-588)4008528-4 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4008528-4 (DE-588)1071861417 |
| title | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| title_auth | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| title_exact_search | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| title_full | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| title_fullStr | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| title_full_unstemmed | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| title_short | Evolving options and future challenges for targeted therapies in ErbB2 (HER2)-positive breast cancer |
| title_sort | evolving options and future challenges for targeted therapies in erbb2 her2 positive breast cancer based on the glaxosmithkline sponsored satellite symposium held at ecco 14 24th september 2007 barcelona spain |
| title_sub | based on the GlaxoSmithKline-sponsored satellite symposium, held at ECCO 14, 24th September 2007, Barcelona, Spain |
| topic | Therapie (DE-588)4059798-2 gnd Brustkrebs (DE-588)4008528-4 gnd |
| topic_facet | Therapie Brustkrebs Konferenzschrift |
| volume_link | (DE-604)BV017615175 |
| work_keys_str_mv | AT europeancancerconferencebarcelona evolvingoptionsandfuturechallengesfortargetedtherapiesinerbb2her2positivebreastcancerbasedontheglaxosmithklinesponsoredsatellitesymposiumheldatecco1424thseptember2007barcelonaspain |